SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-039315
Filing Date
2024-05-03
Accepted
2024-05-03 07:24:48
Documents
14
Period of Report
2024-04-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0205208-8ka1_aditxt.htm   iXBRL 8-K/A 39041
2 REINSTATEMENT AND FOURTH AMENDMENT TO THE MERGER AGREEMENT DATED MAY 2, 2024 ea020520801ex2-1_aditxt.htm EX-2.1 29358
  Complete submission text file 0001213900-24-039315.txt   256053

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE adtx-20240426.xsd EX-101.SCH 3009
4 XBRL LABEL FILE adtx-20240426_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE adtx-20240426_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0205208-8ka1_aditxt_htm.xml XML 4617
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39336 | Film No.: 24910790
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)